$73.27
0.16% yesterday
Nasdaq, Jun 27, 10:13 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$73.27
-0.39 0.53% 1M
+2.85 4.05% 6M
+4.07 5.88% YTD
+9.18 14.32% 1Y
-4.75 6.09% 3Y
+15.21 26.20% 5Y
+17.53 31.44% 10Y
+57.20 355.94% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+0.12 0.16%
ISIN
US8064071025
Symbol
HSIC
Sector

Key metrics

Basic
Market capitalization
$8.9b
Enterprise Value
$11.7b
Net debt
$2.8b
Cash
$127.0m
Shares outstanding
122.2m
Valuation (TTM | estimate)
P/E
22.54 | 14.73
P/S
0.70 | 0.67
EV/Sales
0.92 | 0.88
EV/FCF
23.00
P/B
2.71
Financial Health
Equity Ratio
33.21%
Return on Equity
11.49%
ROCE
10.27%
ROIC
6.30%
Debt/Equity
0.87
Financials (TTM | estimate)
Revenue
$12.7b | $13.2b
EBITDA
$1.0b | $1.1b
EBIT
$777.0m
Net Income
$407.0m | $607.9m
Free Cash Flow
$508.0m
Growth (TTM | estimate)
Revenue
1.75% | 4.28%
EBITDA
15.88% | 11.01%
EBIT
17.55%
Net Income
4.90% | 55.88%
Free Cash Flow
9.48%
Margin (TTM | estimate)
Gross
31.60%
EBITDA
8.12% | 8.54%
EBIT
6.13%
Net
3.21% | 4.60%
Free Cash Flow
4.01%
More
EPS
$3.25
FCF per Share
$4.16
Short interest
7.35%
Employees
25.00k
Rev per Employee
$510.00k
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

11x Buy
48%
11x Hold
48%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

Buy
48%
Hold
48%
Sell
4%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12,669 12,669
2% 2%
100%
- Direct Costs 8,665 8,665
1% 1%
68%
4,004 4,004
2% 2%
32%
- Selling and Administrative Expenses 2,975 2,975
1% 1%
23%
- Research and Development Expense - -
-
-
1,029 1,029
16% 16%
8%
- Depreciation and Amortization 252 252
11% 11%
2%
EBIT (Operating Income) EBIT 777 777
18% 18%
6%
Net Profit 407 407
5% 5%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Neutral
Business Wire
25 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentat...
Neutral
Business Wire
about one month ago
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises t...
Positive
Seeking Alpha
about one month ago
HSIC's Q1 earnings were solid, with full-year EPS guidance of $4.80-$4.94 and analysts expecting $5.27 in 2026. New business units and revamped sales incentives aim to reignite revenue growth after stagnation since 2022; management is optimistic about their impact. Ongoing share buybacks (32% reduction in shares since 2011) continue to support EPS and provide downside support for the stock.
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today